miR-146a negatively regulates the nuclear factor kappa-light-chain-enhancer of activated B (NF-κB) signaling pathway via downregulation of tumor necrosis factor receptor-associated factor 6 (TRAF6), thereby blocking the activation of factors that contribute to the survival of melanoma cells. This evidence concerns the gene NFKB1 and melanoma.